Sofpironium Bromide for the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cureus · 09.05.2026
DOI: 10.7759/cureus.108570 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 09.05.2026. Verfasst von Devanie Martani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universitas Tarumanagara, Jakarta, IDN. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Universitas Tarumanagara, Jakarta, IDN.
- Faculty of Medicine, Faculdade de Ciências Médicas de Santos, Santos, BRA.
- Dermatology, Clínica Concept, Mogi das Cruzes, BRA.
- Faculty of Medicine, Faculdade Pernambucana de Saúde, Recife, BRA.
- Faculty of Medicine, Universidad Autonoma de Nuevo León (UANL), Monterrey, MEX.
- Faculty of Medicine, Universidad del Pacifico, Pedro Juan Caballero, PRY.
Zitieren
APA
Martani, D., Silva, M. S., Nakanishi, L., Valente, L. F., Garza-Dueñas, G. G., Silva, M. O., & Crocco, E. I. (2026). Sofpironium Bromide for the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus. https://doi.org/10.7759/cureus.108570
Vancouver
Martani D, Silva MS, Nakanishi L, Valente LF, Garza-Dueñas GG, Silva MO, et al. Sofpironium Bromide for the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus. 2026. doi:10.7759/cureus.108570
BibTeX
@article{Martani2026,
author = {Martani, Devanie and Silva, Milena S and Nakanishi, Luciana and Valente, Laís F and Garza-Dueñas, Georgina G and Silva, Meire O and Crocco, Elisete I},
title = {Sofpironium Bromide for the Treatment of Primary Axillary Hyperhidrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108570}
}
EUVIMED